US20010054574A1 - Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same - Google Patents
Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same Download PDFInfo
- Publication number
- US20010054574A1 US20010054574A1 US09/916,560 US91656001A US2001054574A1 US 20010054574 A1 US20010054574 A1 US 20010054574A1 US 91656001 A US91656001 A US 91656001A US 2001054574 A1 US2001054574 A1 US 2001054574A1
- Authority
- US
- United States
- Prior art keywords
- coal tar
- distillation
- tar extract
- ppm
- dermatological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
- B60K15/00—Arrangement in connection with fuel supply of combustion engines or other fuel consuming energy converters, e.g. fuel cells; Mounting or construction of fuel tanks
- B60K15/03—Fuel tanks
- B60K15/04—Tank inlets
- B60K15/05—Inlet covers
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
- C10C1/00—Working-up tar
- C10C1/04—Working-up tar by distillation
- C10C1/16—Winning of pitch
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
- C10C3/00—Working-up pitch, asphalt, bitumen
- C10C3/06—Working-up pitch, asphalt, bitumen by distillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Definitions
- the present invention relates to a coal tar extract with a reduced content of polycyclic aromatic hydrocarbons, to a process for obtaining it and to dermocosmetic compositions containing it.
- coal tar means the by-product of the destructive distillation of bituminous coal distilling between at 300 and 370° C. This is a black viscous liquid whose characteristic odor resembles that of naphthalene.
- coal pitch means the residue from the distillation of coal tar.
- Crude coal tar contains a large proportion of polycyclic aromatic hydrocarbons (PAH) of the order of 100,000 ppm.
- PAH polycyclic aromatic hydrocarbons
- Among the predominant PAHs which have been identified are fluoranthene, pyrene, anthracene, phenanthrene, fluorene, 1,2-benzofluorene, 2,3-benzofluorene, 1,2-benzanthracene, chrysene, benzo(k)-fluoranthene, benzo(a)fluoranthene, benzo(b)fluoranthene, benzo(e)pyrene, benzo(a)pyrene (BaP), indeno(1,2,3,c,d)pyrene, 1,2,5,6-dibenzanthracene, benzo(6)chrysene and benzo(g,h,i)perylene, the last thirteen compounds having toxic properties.
- Coal tar is commonly used in antidandruff treatment, in the treatment of certain types of dermatitis such as eczema, lichenification and psoriasis. Before being incorporated into dermatological compositions, coal tar undergoes a purification intended to make it colorless, odorless and substantially free of irritant properties.
- Patent U.S. Pat. No. 3,766,052 published on Oct. 16, 1973 describes a process for purifying commercially available coal tar, which comprises mixing the said coal tar with a C 15 -C 22 fatty acid ester, adding squalane or squalene, and recovering the purified coal tar in the form of the supernatant liquid.
- the coal tar obtained has a viscosity of between 10 and 50 mPa.s and a density at 25° C. of between 0.88 and 0.95. It is used as an active ingredient in dermatological compositions in a proportion from 1 to 10% by weight.
- Patent U.S. Pat. No. 3,928,579 (Warner Lambert Co.) published on Dec. 23, 1975 describes a process for purifying crude coal tar, which consists:
- the solvents used are C 3 -C 6 alkanes or CFCs.
- the purified coal tar is incorporated in the dermatological composition.
- Patent application JP-55 153 710 published on Nov. 30, 1980 describes a cosmetic skin composition containing, as active ingredient, purified tar obtained by distillation of mineral, animal or plant tar under reduced pressure, by diazotization and then by hydrolysis or heating.
- the tars used are coal tar and soybean tar.
- Patent application EP-A-465,434 describes tar oil obtained by fractional distillation of naphthalene oil on three rectification columns in series between 230 and 330° C.
- the naphthalene oil itself is obtained from the distillation of coal pitch.
- this extract can contain a BaP percentage of less than 2 ppm (parts per million). However, at the industrial scale, a BaP percentage of about 20 ppm will be selected.
- the present invention relates to a coal tar extract with a reduced content of both PAH and BaP.
- the coal tar extract according to the invention is characterized by a maximum PAH content of about ten ppm and by a maximum BaP content of about a few ppm.
- the coal tar extracted according to the invention is preferably characterized by a PAH content of less than about 4 ppm and a BaP content of less than about 1 ppm.
- the present invention also relates to a process for obtaining the said coal tar extract from crude coal tar which uses at least two distillation systems connected in series.
- a thin-film evaporator is advantageously chosen as the first distillation system, and/or a distillation column as the second system.
- the distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, at a temperature of between 198 and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h.
- the distillation yield according to the invention using a thin-film evaporator coupled to a distillation column is between 20 and 25% by weight.
- Crude coal tar is commercially available and corresponds to the definition in the French Pharmacopea and/or in the US Pharmacopea. Its respective contents of PAH and of BaP are about 93,000 and 2000-10,000 ppm.
- the present invention relates to cosmetic or dermatological compositions containing the coal tar extract according to the invention, preferably in a proportion of from 0.1 to 10% by weight.
- a cosmetic or dermatological composition containing 0.5% of coal tar extract with 1 ppm of BaP has respective contents of PAH and BaP of about 15 and 2 ppb (parts per billion).
- compositions are proposed under the same therapeutic indications as crude coal tar.
- Example 1 SHAMPOO PURIFIED WATER qs 100 g PULVERIZED SALICYCLIC ACID 1.50 g UNDECYLENIC DERIVATIVE 1 to 3 g QUATERNARY POLYMER 0.5 to 1 g ETHOXYLATED SODIUM ALKYL SULFATE 9 g POLYSORBATE-20 5 to 7 g FATTY ACID ETHANOLAMIDE PEG-6000 DISTEARATE 5 g ALKYLAMIDO BETAINE 1.5 g COCOAMPHODIACETATE 3.5 g DISODIUM EDTA 0.2 g 20 POE SORBITAN MONOLAURATE 5 g FRAGRANCE QS DYE QS COAL TAR 0.1 ⁇ g 2.50
- Example 2 SHAMPOO WATER qs 100 g SODIUM LAURETH SULFATE 8 g POLYSORBATE 7 g PEG-150 DISTEARATE 4
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Sustainable Energy (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Civil Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Structural Engineering (AREA)
- Transportation (AREA)
- Combustion & Propulsion (AREA)
- Sustainable Development (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention concerns a coal tar extract with reduced polycyclic aromatic hydrocarbon content and a method for obtaining same using two sequentially linked distillation systems. The invention also concerns cosmetic and dermatological preparations containing said resulting coal tar extract.
Description
- The present invention relates to a coal tar extract with a reduced content of polycyclic aromatic hydrocarbons, to a process for obtaining it and to dermocosmetic compositions containing it.
- The term “coal tar” means the by-product of the destructive distillation of bituminous coal distilling between at 300 and 370° C. This is a black viscous liquid whose characteristic odor resembles that of naphthalene.
- The term “coal pitch” means the residue from the distillation of coal tar.
- Crude coal tar contains a large proportion of polycyclic aromatic hydrocarbons (PAH) of the order of 100,000 ppm. Among the predominant PAHs which have been identified are fluoranthene, pyrene, anthracene, phenanthrene, fluorene, 1,2-benzofluorene, 2,3-benzofluorene, 1,2-benzanthracene, chrysene, benzo(k)-fluoranthene, benzo(a)fluoranthene, benzo(b)fluoranthene, benzo(e)pyrene, benzo(a)pyrene (BaP), indeno(1,2,3,c,d)pyrene, 1,2,5,6-dibenzanthracene, benzo(6)chrysene and benzo(g,h,i)perylene, the last thirteen compounds having toxic properties.
- Coal tar is commonly used in antidandruff treatment, in the treatment of certain types of dermatitis such as eczema, lichenification and psoriasis. Before being incorporated into dermatological compositions, coal tar undergoes a purification intended to make it colorless, odorless and substantially free of irritant properties.
- Many processes for purifying coal tar are described in the literature.
- Patent U.S. Pat. No. 3,766,052 (Warner Lambert Co.) published on Oct. 16, 1973 describes a process for purifying commercially available coal tar, which comprises mixing the said coal tar with a C15-C22 fatty acid ester, adding squalane or squalene, and recovering the purified coal tar in the form of the supernatant liquid. The coal tar obtained has a viscosity of between 10 and 50 mPa.s and a density at 25° C. of between 0.88 and 0.95. It is used as an active ingredient in dermatological compositions in a proportion from 1 to 10% by weight.
- Patent U.S. Pat. No. 3,928,579 (Warner Lambert Co.) published on Dec. 23, 1975 describes a process for purifying crude coal tar, which consists:
- 1) of an extraction with a volatile solvent or mixture of solvents whose kauri butanol number is less than 75 and whose boiling point is less than 80° C.,
- 2) of a filtration, and then
- 3) of an evaporation of the volatile solvent(s).
- The solvents used are C3-C6 alkanes or CFCs.
- The purified coal tar is incorporated in the dermatological composition.
- Patent application JP-55 153 710 (Fujunaga Seiyaku) published on Nov. 30, 1980 describes a cosmetic skin composition containing, as active ingredient, purified tar obtained by distillation of mineral, animal or plant tar under reduced pressure, by diazotization and then by hydrolysis or heating. The tars used are coal tar and soybean tar.
- The distillation carried out from 50 to 120° C. under a vacuum of 5-10 mmHg allows the mutagenic properties of the tar to be reduced by a factor of 20. Diazotization with an excess of nitrite followed by an increase in temperature and optionally a hydrolysis makes it possible to reduce the mutagenic properties of the tar by a factor of 90.
- Among the PAHs contained in coal tar whose toxic properties have been recognized, it has been found that BaP exhibits carcinogenic properties in the event of prolonged use.
- Patent application EP-A-465,434 describes tar oil obtained by fractional distillation of naphthalene oil on three rectification columns in series between 230 and 330° C. The naphthalene oil itself is obtained from the distillation of coal pitch.
- At the experimental stage, this extract can contain a BaP percentage of less than 2 ppm (parts per million). However, at the industrial scale, a BaP percentage of about 20 ppm will be selected.
- The present invention relates to a coal tar extract with a reduced content of both PAH and BaP.
- The coal tar extract according to the invention is characterized by a maximum PAH content of about ten ppm and by a maximum BaP content of about a few ppm.
- The coal tar extracted according to the invention is preferably characterized by a PAH content of less than about 4 ppm and a BaP content of less than about 1 ppm.
- The present invention also relates to a process for obtaining the said coal tar extract from crude coal tar which uses at least two distillation systems connected in series.
- A thin-film evaporator is advantageously chosen as the first distillation system, and/or a distillation column as the second system.
- The distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, at a temperature of between 198 and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h.
- The column distillation following distillation on a thin-film evaporator is carried out at between 260 and 320° C.
- The distillation yield according to the invention using a thin-film evaporator coupled to a distillation column is between 20 and 25% by weight.
- Crude coal tar is commercially available and corresponds to the definition in the French Pharmacopea and/or in the US Pharmacopea. Its respective contents of PAH and of BaP are about 93,000 and 2000-10,000 ppm.
- The present invention relates to cosmetic or dermatological compositions containing the coal tar extract according to the invention, preferably in a proportion of from 0.1 to 10% by weight.
- A cosmetic or dermatological composition containing 0.5% of coal tar extract with 1 ppm of BaP has respective contents of PAH and BaP of about 15 and 2 ppb (parts per billion).
- The said compositions are proposed under the same therapeutic indications as crude coal tar.
- The examples which follow illustrate the invention without limiting its scope.
Example 1: SHAMPOO PURIFIED WATER qs 100 g PULVERIZED SALICYCLIC ACID 1.50 g UNDECYLENIC DERIVATIVE 1 to 3 g QUATERNARY POLYMER 0.5 to 1 g ETHOXYLATED SODIUM ALKYL SULFATE 9 g POLYSORBATE-20 5 to 7 g FATTY ACID ETHANOLAMIDE PEG-6000 DISTEARATE 5 g ALKYLAMIDO BETAINE 1.5 g COCOAMPHODIACETATE 3.5 g DISODIUM EDTA 0.2 g 20 POE SORBITAN MONOLAURATE 5 g FRAGRANCE QS DYE QS COAL TAR 0.1 → g 2.50 Example 2: SHAMPOO WATER qs 100 g SODIUM LAURETH SULFATE 8 g POLYSORBATE 7 g PEG-150 DISTEARATE 4 g SODIUM UNDECYLENAMIDO MEA-SULFOSUCCINATE 3 g SODIUM COCOAMPHODIACETATE 3 g SALICYCLIC ACID 1.5 g FRAGRANCE 0.5 g T.E.A.-HYDROLYZED COCOYL-COLLAGEN 1 g COAL TAR 0.1 → 1 g Example 3: LOTION WATER qs 100 ml SD-ALCOHOL 39-C 63 ml FRAGRANCE 0.20 g VINYL ACETATE/CROTONIC ACID COPOLYMER 0.15 g PEG-13 OCTANOATE 0.10 g LAURYLPYRIDINIUM CHLORIDE 0.05 g COAL TAR 0.1 → 1 g Example 4: CREAM WATER qs 100 g PEG-40 SORBITAN LANOLATE 7.5 g PARAFFIN 5 g PROPYLENE GLYCOL 5 g CETYL ALCOHOL 3 g POLYSORBATE 3 g LANOLIN 2 g SALICYCLIC ACID 1.5 g FRAGRANCE 0.4 g COAL TAR 0.1 → 3 g Example 5: OIL MINERAL OIL qs 100 g DIBUTYL ADIPATE 15 g CAPRYLIC/CAPRIC TRIGLYCERIDE 10 g COAL TAR 0.1 → 2 g Example 6: SYNDET SODIUM HEMISULFOSUCCINATE qs 100 g SODIUM ISOTHIONATE 20 g WAX OF MINERAL ORIGIN 12 g CETYL ALCOHOL 13 g WHEAT STARCH 20 g PINE TAR 0.3 g CADE TAR 0.3 g SALICYCLIC ACID 2 g ZINC OXIDE 5 g COAL TAR 0.1 → 2 g Example 7: MOUSSE DEMINERALIZED WATER qs 100 g GUAR GUM 0.10 g JOJOBA OIL 2 g ETHYLHEXYL P-METHOXYCINNAMATE 1 g VINYLPYRROLIDONE/DMAE METHACRYLATE 1 g PVP HEXADECENE COPOLYMER 2 g DIMETHYL/TRIMETHYL-POLYSILOXANE 1 g CETRIMONIUM BROMIDE 0.40 g FRAGRANCE 0.15 g COAL TAR 0.1 → 2 g Example 8: EMOLLIENT SOLUTION PROPYLENE GLYCOL qs 100 g CADE TAR 10 g PINE TAR 10 g POLYSORBATE 20 g POLYETHOXYLATED COCONUT FATTY ESTERS 10 g POLYETHOXYLATED ALKYLPHENOL 10 g FRAGRANCE 1 g COAL TAR 0.1 → 5 g Example 9: GELLED BODY OIL CAPRYLIC/CAPRIC TRIGLYCERIDE 20 → 30 g MINERAL OIL 36 g PETROLATUM 15 g PEG-40 SORBITOL HEXAOLEATE 8 g QUATERNIUM-18 HECTORITE 5 g HYDROGENATED TALLOWETH-60 MYRISTYL GLYCOL 5 g FRAGRANCE 0.5 g BENZOIC ACID 0.3 g PROPYL GALLATE 0.02 g COAL TAR 0.1 → 2 g
Claims (8)
1. Coal tar extract, characterized in that its maximum content of polycyclic aromatic hydrocarbons is about ten parts per million (ppm) and its maximum content of benzo(a)pyrene is about a few ppm.
2. Coal tar extract according to , characterized in that its content of polycyclic aromatic hydrocarbons is less than about 4 ppm and its content of benzo(a)pyrene is less than about 1 ppm.
claim 1
3. Process for obtaining a coal tar extract according to or , from crude coal tar, characterized in that it uses at least two distillation systems connected in series.
claim 1
2
4. Process according to , characterized in that the first system is a thin-film evaporator and/or the second system is a distillation column.
claim 3
5. Process according to , characterized in that the distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, between 198° C. and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h.
claim 4
6. Process according to , characterized in that the distillation on a distillation column following distillation on a thin-film evaporator is carried out at from 260° C. to 320° C.
claim 5
7. Cosmetic or dermatological compositions containing a coal tar extract according to or or obtained by the process according to one of to .
claim 1
2
claims 3
6
8. Cosmetic or dermatological compositions according to , characterized in that they contain 0.1 to 10% by weight of coal tar extract.
claim 7
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/916,560 US20010054574A1 (en) | 1997-03-11 | 2001-07-27 | Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9702835 | 1997-03-11 | ||
FR9702835A FR2760637B1 (en) | 1997-03-11 | 1997-03-11 | COAL TAR EXTRACT WITH REDUCED AROMATIC HYDROCARBON CONTENT, PROCESS FOR OBTAINING AND DERMO-COSMETIC PREPARATIONS |
US09/380,958 US6319392B1 (en) | 1997-03-11 | 1998-03-11 | Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions |
US09/916,560 US20010054574A1 (en) | 1997-03-11 | 2001-07-27 | Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/380,958 Continuation US6319392B1 (en) | 1997-03-11 | 1998-03-11 | Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20010054574A1 true US20010054574A1 (en) | 2001-12-27 |
Family
ID=9504586
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/380,958 Expired - Lifetime US6319392B1 (en) | 1997-03-11 | 1998-03-11 | Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions |
US09/916,560 Abandoned US20010054574A1 (en) | 1997-03-11 | 2001-07-27 | Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/380,958 Expired - Lifetime US6319392B1 (en) | 1997-03-11 | 1998-03-11 | Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions |
Country Status (5)
Country | Link |
---|---|
US (2) | US6319392B1 (en) |
EP (1) | EP0964901A1 (en) |
CA (1) | CA2284871A1 (en) |
FR (1) | FR2760637B1 (en) |
WO (1) | WO1998040447A1 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120237453A1 (en) * | 2002-10-25 | 2012-09-20 | Foamix Ltd. | Sensation modifying topical composition foam |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050003023A1 (en) * | 2002-06-28 | 2005-01-06 | Meisner Lorraine Faxon | Topical composition for the treatment of psoriasis and related skin disorders |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
US7033485B2 (en) * | 2001-05-11 | 2006-04-25 | Koppers Industries Of Delaware, Inc. | Coal tar and hydrocarbon mixture pitch production using a high efficiency evaporative distillation process |
US20050095378A1 (en) * | 2003-11-03 | 2005-05-05 | Scarpone Stephen P. | Hybrid coatings derived from bituminous and petroleum bases |
US11248172B2 (en) | 2019-07-23 | 2022-02-15 | Koppers Delaware, Inc. | Heat treatment process and system for increased pitch yields |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928579A (en) * | 1974-11-25 | 1975-12-23 | Warner Lambert Co | Process for the purification of coal tar |
JPS55153710A (en) * | 1979-05-17 | 1980-11-29 | Fujinaga Seiyaku Kk | Skin cosmetic |
US4409094A (en) * | 1980-08-08 | 1983-10-11 | Massachusetts Institute Of Technology | Process for detoxifying coal tars |
WO1982002047A1 (en) * | 1980-12-10 | 1982-06-24 | Sakuma Kiyoshi | Process for producing dibenzofuran |
IT1243219B (en) * | 1990-06-26 | 1994-05-24 | Margaritelli Spa | DISTILLED, FRACTIONATED AND RECTIFIED TAR OIL TO BE USED FOR THE ECOLOGICAL IMPREGNATION OF WOOD. |
DE4112955A1 (en) * | 1991-04-20 | 1992-10-22 | Ruetgerswerke Ag | STEINKOHLENTEERPECH, ITS MANUFACTURE AND USE |
DE4119170C2 (en) * | 1991-06-11 | 2002-04-25 | Geb Herber Miltner | Remedies for atopic dermatitis |
US6010617A (en) * | 1992-11-13 | 2000-01-04 | Mobil Oil Corporation | Process for producing non-carcinogenic coal-tar-derived products |
US5746906A (en) * | 1995-08-10 | 1998-05-05 | Koppers Industries, Inc. | Coal tar pitch blend having low polycyclic aromatic hydrocarbon content and method of making thereof |
-
1997
- 1997-03-11 FR FR9702835A patent/FR2760637B1/en not_active Expired - Lifetime
-
1998
- 1998-03-11 US US09/380,958 patent/US6319392B1/en not_active Expired - Lifetime
- 1998-03-11 WO PCT/FR1998/000488 patent/WO1998040447A1/en not_active Application Discontinuation
- 1998-03-11 EP EP98913885A patent/EP0964901A1/en not_active Withdrawn
- 1998-03-11 CA CA002284871A patent/CA2284871A1/en not_active Abandoned
-
2001
- 2001-07-27 US US09/916,560 patent/US20010054574A1/en not_active Abandoned
Cited By (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
US9320705B2 (en) * | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US20120237453A1 (en) * | 2002-10-25 | 2012-09-20 | Foamix Ltd. | Sensation modifying topical composition foam |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Also Published As
Publication number | Publication date |
---|---|
FR2760637A1 (en) | 1998-09-18 |
FR2760637B1 (en) | 1999-05-28 |
CA2284871A1 (en) | 1998-09-17 |
EP0964901A1 (en) | 1999-12-22 |
US6319392B1 (en) | 2001-11-20 |
WO1998040447A1 (en) | 1998-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6319392B1 (en) | Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions | |
EP2005939A1 (en) | Cosmetic and dermatological preparations with a percentage of molecular oxygen and perfume substances | |
DE69626941T2 (en) | Cosmetic preparations containing a polyphenol from Rosaceae fruits | |
JP4781062B2 (en) | Skin preparation for moisturizing or improving rough skin | |
EP0688210B1 (en) | Use of carnosine in combination with urocanic acid for treatment of photodermatoses | |
DE3100064A1 (en) | COSMETIC PREPARATION FOR TREATING THE SKIN AND HAIR | |
KR100325317B1 (en) | Pharmaceutical and cosmetic antiacne formulations containing plant extracts (Krameria triandra or Mesua ferrea) | |
DE68903887T2 (en) | TRANSPARENT COSMETIC EMULSION. | |
WO2011124244A2 (en) | Microbiologically stable, easily applicable preparations comprising active substances susceptible to degradation | |
WO1999037275A2 (en) | COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A LESS STICKY FEEL, CONTAINING GLYCERIN ESTERS OF α-HYDROXY CARBOXYLIC ACIDS AND SATURED FATTY ACIDS | |
EP0911019B1 (en) | Deodorizing compositions based on flavone derivatives and/or flavanone derivatives, especially flavonoids | |
US5037641A (en) | Beauty preparations having anti-fading effect and a process for preparing the same | |
DE69314463T2 (en) | SKIN REGENERATING COSMETIC COMPOSITION | |
JPH108049A (en) | Antioxidant composition | |
EP2090296B1 (en) | Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy | |
EP3111919B1 (en) | Emulsions containing cationic emulsifiers based on mdipa esterquats | |
DE10032165A1 (en) | Use of physiologically tolerable sulfinic acids as antioxidant or free radical scavenger in cosmetic or dermatological preparations | |
JPH11171723A (en) | Antioxidant | |
KR102247589B1 (en) | Cosmetic composition for improving skin comprising the moluccella laevis extraction and the hololeion maximowiczii Kitam. extraction as an effective ingredient | |
EP1069884A1 (en) | Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids | |
DE19739349A1 (en) | Use of troxerutin as antioxidant and/or radical scavenger | |
JPH0615449B2 (en) | External water phase type cosmetics | |
WO2007096090A1 (en) | Active substance combinations of hydroxymatairesinol, phenoxyethanol and, if desired, glycerin | |
JP3491755B1 (en) | External preparation for skin | |
EP0049424B1 (en) | Bioactive composition containing vegetable agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |